Senseonics (SENS) Trading Down 10.8%

Senseonics Holdings Inc (NYSEAMERICAN:SENS)’s share price fell 10.8% during mid-day trading on Thursday . The stock traded as low as $2.65 and last traded at $2.65. 3,555,995 shares were traded during trading, an increase of 98% from the average session volume of 1,792,478 shares. The stock had previously closed at $2.97.

SENS has been the topic of a number of analyst reports. Zacks Investment Research lowered Senseonics from a “hold” rating to a “sell” rating in a research report on Wednesday, February 6th. Piper Jaffray Companies initiated coverage on Senseonics in a research report on Tuesday, January 29th. They issued a “neutral” rating on the stock. Finally, UBS Group initiated coverage on Senseonics in a report on Tuesday, November 27th. They issued a “sell” rating on the stock. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $6.00.

Senseonics (NYSEAMERICAN:SENS) last released its quarterly earnings results on Tuesday, March 12th. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.11. The company had revenue of $7.20 million for the quarter, compared to analysts’ expectations of $7.89 million.

A number of hedge funds have recently bought and sold shares of the business. Raymond James Trust N.A. increased its holdings in Senseonics by 11.4% in the fourth quarter. Raymond James Trust N.A. now owns 49,000 shares of the company’s stock valued at $127,000 after buying an additional 5,000 shares during the last quarter. Cerity Partners LLC grew its holdings in Senseonics by 33.3% in the 4th quarter. Cerity Partners LLC now owns 20,000 shares of the company’s stock worth $52,000 after buying an additional 5,000 shares in the last quarter. Amalgamated Bank acquired a new stake in Senseonics in the fourth quarter worth approximately $28,000. Principal Financial Group Inc. lifted its position in Senseonics by 78.0% in the fourth quarter. Principal Financial Group Inc. now owns 25,259 shares of the company’s stock worth $65,000 after purchasing an additional 11,071 shares during the period. Finally, New York State Common Retirement Fund lifted its position in Senseonics by 25.0% in the fourth quarter. New York State Common Retirement Fund now owns 65,500 shares of the company’s stock worth $170,000 after purchasing an additional 13,100 shares during the period. 30.66% of the stock is owned by hedge funds and other institutional investors.

WARNING: “Senseonics (SENS) Trading Down 10.8%” was originally published by Markets Daily and is the sole property of of Markets Daily. If you are accessing this piece on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The original version of this piece can be viewed at https://www.themarketsdaily.com/2019/03/15/senseonics-sens-trading-down-10-8.html.

Senseonics Company Profile (NYSEAMERICAN:SENS)

Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.

Featured Article: What is the Ex-Dividend Date in Investing?

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.